New cycler

Outstanding diagnostic performance of the M371-Test on new qPCR platforms

mir|detect has the M371-Test for the detection of testicular germ cell tumours has been validated for use on two new qPCR platforms:

  • AriaDx (Agilent)
  • QuantStudio 5 (ThermoFisher Scientific)

The M371-Test offers the same excellent diagnostic performance on both devices as on the LightCycler 480 II, increasing accessibility for laboratories and thus the number of patients treated by the M371-Test benefit.

The company continues to work mir|detect working flat out on the validation of the M371-Test on the LightCycler PRO (Roche) and the CFX96 (Bio-Rad) for the M371-Test accessible to many patients and users.

Copyright by me|detect & 21HAVN